An implanted biofuel cell (IBFC) is a novel device that provides the means to create electricity from glucose and oxygen, using an original architecture for the IBFC that provides efficient work inside a living organism. In the future these IBFCs will be required to power implanted devices to assist failing physiological functions in humans. The active ingredients of such IBFCs are glucose oxidase at the anode and laccase at the cathode. These enzymes are entrapped in a 3D network of conductive and insulated materials. This publication solves the issue of the sterilization of such a complex device, using gamma irradiation. A 12kGy dose was sufficient to show absence of implant infection in all the implantations performed. We also prove in vitro functioning of both bioelectrodes with a high dose of 42kGy.

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20163208027DOI Listing

Publication Analysis

Top Keywords

[shades grays
4
grays implanting
4
implanting enzymatic
4
enzymatic biofuel
4
biofuel cell]
4
cell] implanted
4
implanted biofuel
4
biofuel cell
4
cell ibfc
4
ibfc novel
4

Similar Publications

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.

N Engl J Med

February 2022

From Novavax, Gaithersburg (L.M.D., G.A., K.S., W.W., I.C., G.M.G., F.D.), the University of Maryland School of Medicine, Baltimore (K.L.K., M.A.M., K.M.N.), the National Institute of Allergy and Infectious Diseases, Bethesda (J.H.), and Walter Reed Army Institute of Research, Silver Spring (J.A.A.) - all in Maryland; FAICIC Clinical Research, Veracruz (A.Q.B.H.), and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City (G.M.R.-P.) - both in Mexico; Research Your Health, Plano (J.M.A.) and the Texas Center for Drug Development, Houston (V.G.-F.) - both in Texas; M3-Wake Research, Raleigh (W.L.H.), M3-Emerging Medical Research, Durham (D.B.M.), and the University of North Carolina School of Medicine, Chapel Hill (C.L.G.) - all in North Carolina; SIMEDHealth, Gainesville (D.M.D.), and Velocity Clinical Research, Hallandale Beach (B.E.S.) - both in Florida; the University of Nebraska Medical Center, Omaha (D.F.F.); the University of Washington Medical Center (R.S.M., R.W.C., A.L.G.) and Fred Hutchinson Cancer Research Center (L.C.), Seattle, and Lummi Indian Health Center, Bellingham (D.C.L.) - all in Washington; the Atlanta Center for Medical Research, Atlanta (R.A.R.), and IACT Health, Columbus (J.K.K.) - both in Georgia; Velocity Clinical Research-Providence, Warwick, RI (D.L.F.); WR ClinSearch, Chattanooga, TN (M.M.); MedPharmics, Metairie, LA (R.J.J.); and Black Hills Center for American Indian Health, Rapid City, SD (J.A.H.).

Background: NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (Covid-19) in phase 2b-3 trials in the United Kingdom and South Africa, but its efficacy had not yet been tested in North America.

Methods: We conducted a phase 3, randomized, observer-blinded, placebo-controlled trial in the United States and Mexico during the first half of 2021 to evaluate the efficacy and safety of NVX-CoV2373 in adults (≥18 years of age) who had not had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Participants were randomly assigned in a 2:1 ratio to receive two doses of NVX-CoV2373 or placebo 21 days apart.

View Article and Find Full Text PDF

An implanted biofuel cell (IBFC) is a novel device that provides the means to create electricity from glucose and oxygen, using an original architecture for the IBFC that provides efficient work inside a living organism. In the future these IBFCs will be required to power implanted devices to assist failing physiological functions in humans. The active ingredients of such IBFCs are glucose oxidase at the anode and laccase at the cathode.

View Article and Find Full Text PDF

Many arthropod species have evolved to thrive only on the leaves of a particular species of plant, which they must be capable of finding in order to survive accidental displacement, developmental transitions or the changing of the seasons. A number of studies have tested whether such species select leaves to land or oviposit on based on their color, shape or size. Unfortunately, many studies did not control for correlates of these characters, such as the brightness of different colors, the areas of different shapes, and the level of ambient illumination in the vicinity of different sizes of leaves.

View Article and Find Full Text PDF

Objective: The objective of this study was to undertake a clinical evaluation of the individual repeatability of three colour measuring devices.

Design: Clinical study. Setting Eastman Dental Hospital.

View Article and Find Full Text PDF

The place of white in a world of grays: a double-anchoring theory of lightness perception.

Psychol Rev

July 2006

Dipartimento di Psicologia Generale, Universita di Padova, Via Venezia 8, 35131 Padua, Italy.

The specific gray shades in a visual scene can be derived from relative luminance values only when an anchoring rule is followed. The double-anchoring theory I propose in this article, as a development of the anchoring theory of Gilchrist et al. (1999), assumes that any given region (a) belongs to one or more frameworks, created by Gestalt grouping principles, and (b) is independently anchored, within each framework, to both the highest luminance and the surround luminance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!